Extracellular Vesicles May Predict Response to Radioembolization and Sorafenib Treatment in Advanced Hepatocellular Carcinoma: An Exploratory Analysis from the SORAMIC Trial.
Timothy Wai Ho ShuenMarianna Alunni-FabbroniElif ÖcalPeter MalfertheinerMoritz WildgruberRegina SchinnerMaciej PechJulia BenckertBruno SangroChristiane K KuhlAntonio GasbarriniPierce Kah-Hoe ChowHan Chong TohJens RickePublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
In this exploratory study, EV-based proteomics predicted response to SIRT+sorafenib and sorafenib-only treatment in patients with advanced HCC of metabolic origin.